Chemcrux Enterp.

Why is Chemcrux Enterprises Ltd falling/rising?

As of 07-Aug, Chemcrux Enterprises Ltd's stock price is declining, currently at 87.71, with a total drop of 11.9% over the last three days and a yearly return of -24.32%. Despite some positive financial indicators, the stock's performance is hindered by a bearish trend and declining investor participation.

As of 07-Aug, Chemcrux Enterprises Ltd's stock price is falling, currently at 87.71, reflecting a decrease of 1.59 (-1.78%). The stock has been on a downward trend, having lost value for the last three consecutive days, resulting in a total decline of 11.9% during this period. This performance is further highlighted by the stock's underperformance against the benchmark, as it has generated a return of -24.32% over the past year, significantly lagging behind the BSE500 index.<BR><BR>The stock's recent performance is also characterized by a decline in investor participation, with the delivery volume dropping by 35.49% compared to the five-day average. Although the company has shown some positive financial indicators, such as a higher PAT of Rs 2.36 crore and a growth in net sales of 32.97% for the latest quarter, these factors have not been sufficient to counterbalance the overall negative sentiment surrounding the stock.<BR><BR>Moreover, the stock's moving averages indicate that it is currently lower than the 5-day, 20-day, 50-day, and 200-day moving averages, which typically suggests a bearish trend. The long-term outlook is also concerning, as the company has experienced a poor growth rate in operating profit of -9.76% annually over the last five years. Collectively, these factors contribute to the stock's decline, indicating a challenging environment for Chemcrux Enterprises Ltd.

Which are the latest news on Chemcrux Enterp.?

Should I buy, sell or hold Chemcrux Enterprises Ltd?

Are Chemcrux Enterprises Ltd latest results good or bad?

Chemcrux Enterprises Ltd's latest results show strong year-on-year growth with a 466.67% increase in net profit and a 32.97% rise in revenue. However, sequential declines in profit and margins indicate potential operational challenges, suggesting investors should be cautious.

Chemcrux Enterprises Ltd's latest results present a mixed picture. On one hand, the company reported a net profit of ₹0.51 crores for Q1 FY27, which is a significant year-on-year increase of 466.67%. Additionally, revenue grew by 32.97% year-on-year, reaching ₹21.94 crores. These figures indicate strong demand and growth compared to the same period last year.<BR><BR>However, the sequential performance raises concerns. The net profit declined by 72.43% compared to the previous quarter, and revenue fell by 9.64%. This decline suggests potential issues with demand sustainability and operational efficiency. Moreover, the operating margin dropped from 17.22% in Q4 FY26 to 12.26%, indicating increased cost pressures. The profit after tax (PAT) margin also fell sharply from 7.62% to 2.32%, primarily due to a high effective tax rate and increased depreciation.<BR><BR>Overall, while the year-on-year growth figures are impressive, the sequential declines in profitability and margins signal underlying challenges that the company needs to address. Investors should approach the stock with caution, considering both the growth potential and the current operational difficulties.

When is the next results date for Chemcrux Enterprises Ltd?

The next results date for Chemcrux Enterprises Ltd is August 4, 2026.

The next results date for Chemcrux Enterprises Ltd is scheduled for August 4, 2026.

What does Chemcrux Enterp. do?

Chemcrux Enterprises Ltd manufactures intermediates for bulk drugs in the specialty chemicals sector and has a market cap of INR 135 Cr. As of March 2026, it reported net sales of 24 Cr and a net profit of 2 Cr.

Overview:<BR>Chemcrux Enterprises Ltd is engaged in the manufacturing of intermediates for bulk drugs within the specialty chemicals industry and operates in the micro-cap market.<BR><BR>History:<BR>The company was incorporated on April 15, 1996, and took over the business of M/s. Chemcrux, a partnership firm established in 1981, in December 1999. The latest quarterly results reported net sales and profit for the period ending March 2026.<BR><BR>Financial Snapshot:<BR>- Net Sales: 24 Cr (Quarterly Results - Mar 2026)<BR>- Net Profit: 2 Cr (Quarterly Results - Mar 2026)<BR>- Market Cap: INR 135 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: 37.00<BR>- Industry P/E: 42<BR>- Dividend Yield: 1.09%<BR>- Debt Equity: 0.21<BR>- Return on Equity: 4.85%<BR>- Price to Book: 1.77<BR><BR>Contact Details:<BR>Address: 330 TRIVIA Complex, Natubhai Circle Racecourse Vadodara Gujarat : 390007<BR>Tel: 91-265-2344803/2358903<BR>Email: girishshah@chemcrux.com<BR>Website: http://www.chemcrux.com

How big is Chemcrux Enterp.?

As of 10th June, Chemcrux Enterprises Ltd has a market capitalization of 135.00 Cr, with net sales of 80.64 Cr and a net profit of 3.73 Cr reported in the latest four quarters.

As of 10th June, Chemcrux Enterprises Ltd has a market capitalization of 135.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Chemcrux Enterprises Ltd reported Net Sales of 80.64 Cr and a Net Profit of 3.73 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, with Shareholder's Funds amounting to 74.62 Cr and Total Assets of 127.05 Cr.

Who are in the management team of Chemcrux Enterp.?

The management team of Chemcrux Enterprises includes Girish Shah (Chairman & Executive Director), Sanjaybhai Marathe (Managing Director), Neela Marathe (Non-Executive Director), and several Independent Directors: Bhanubhai Patel, Shaileshkumar Patel, Mukund P Bakshi, along with Additional Director Sidhdhi Shah.

The management team of Chemcrux Enterprises includes the following individuals:<BR><BR>1. **Girish Shah** - Chairman & Executive Director<BR>2. **Sanjaybhai Marathe** - Executive Director / Managing Director / Promoter<BR>3. **Neela Marathe** - Non-Executive Director<BR>4. **Bhanubhai Patel** - Independent Director<BR>5. **Shaileshkumar Patel** - Independent Director<BR>6. **Mukund P Bakshi** - Independent Director<BR>7. **Sidhdhi Shah** - Additional Director<BR><BR>If you need more specific information about any of the members or their roles, feel free to ask!

Who are the peers of the Chemcrux Enterp.?

Chemcrux Enterp.'s peers include Dai-ichi Karkari, Jaysynth Orgo, Ishan Dyes, Resonance Speci., Polson, Deep Polymers, Alkali Metals, and Ambani Orgochem. Management risk varies from excellent at Ambani Orgochem to below average for most others, with Chemcrux Enterp. showing average risk and a 1-year return of -35.77%.

Peers: The peers of Chemcrux Enterp. are Dai-ichi Karkari, Jaysynth Orgo, Ishan Dyes, Resonance Speci., Polson, Deep Polymers, Alkali Metals, and Ambani Orgochem.<BR><BR>Quality Snapshot: Excellent management risk is observed at Ambani Orgochem, while Average management risk is found at Jaysynth Orgo, Resonance Speci., and Chemcrux Enterp., and the rest have Below Average management risk. Growth is Excellent at Jaysynth Orgo, Average at Deep Polymers, and Below Average at Dai-ichi Karkari, Ishan Dyes, Resonance Speci., Polson, Chemcrux Enterp., Alkali Metals, and Ambani Orgochem. Good capital structure is noted at Dai-ichi Karkari and Chemcrux Enterp., Excellent at Jaysynth Orgo and Resonance Speci., Average at Polson and Deep Polymers, and Below Average at Ishan Dyes, Alkali Metals, and Ambani Orgochem.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Ishan Dyes at 31.54%, while the lowest is Dai-ichi Karkari at -42.93%. Chemcrux Enterp.'s 1-year return of -35.77% is better than Dai-ichi Karkari's but worse than Ishan Dyes'. Additionally, peers with a negative six-month return include Dai-ichi Karkari, Jaysynth Orgo, Chemcrux Enterp., Deep Polymers, and Ambani Orgochem.

Is Chemcrux Enterp. overvalued or undervalued?

As of November 20, 2025, Chemcrux Enterprises is fairly valued with a PE ratio of 92.25, but has underperformed the Sensex with a year-to-date return of -32.58%, raising concerns about its growth prospects in the specialty chemicals sector.

As of 20 November 2025, the valuation grade for Chemcrux Enterprises has moved from expensive to fair. The company is currently fairly valued, with a PE ratio of 92.25, an EV to EBITDA of 22.72, and a Price to Book Value of 2.26. Compared to its peers, Chemcrux's valuation metrics are relatively high; for instance, Solar Industries has a PE of 95.5 and an EV to EBITDA of 58.77, while Godrej Industries is more attractive with a PE of 36.6 and an EV to EBITDA of 40.38.<BR><BR>Despite the fair valuation, Chemcrux has underperformed significantly compared to the Sensex, with a year-to-date return of -32.58% against the Sensex's 9.59%. This stark contrast in performance may indicate potential concerns about the company's growth prospects or market positioning within the specialty chemicals sector.

How has been the historical performance of Chemcrux Enterp.?

Chemcrux Enterp. has shown a declining trend in financial performance over the past three years, with net sales and profits significantly decreasing while total assets and debt increased. The company has struggled with profitability and cash flow, resulting in a net cash outflow in the latest year.

Answer:<BR>The historical performance of Chemcrux Enterp. shows a declining trend in key financial metrics over the past three years.<BR><BR>Breakdown:<BR>Chemcrux Enterp. has experienced a decrease in net sales, dropping from 95.15 Cr in Mar'23 to 70.01 Cr in Mar'25. Total operating income followed a similar trend, declining from 95.15 Cr in Mar'23 to 70.01 Cr in Mar'25. The total expenditure, excluding depreciation, also decreased from 73.70 Cr in Mar'23 to 60.78 Cr in Mar'25. Operating profit (PBDIT) has seen a significant decline from 22.50 Cr in Mar'23 to 10.72 Cr in Mar'25, while profit before tax fell from 19.65 Cr to 5.77 Cr in the same period. Consequently, profit after tax decreased from 14.36 Cr in Mar'23 to 3.91 Cr in Mar'25, reflecting a drop in earnings per share from 9.7 to 2.64. The company's total assets increased from 93.22 Cr in Mar'23 to 127.05 Cr in Mar'25, alongside a rise in total debt from 13.42 Cr to 41.53 Cr. Cash flow from operating activities also declined from 14.00 Cr in Mar'23 to 7.00 Cr in Mar'25, contributing to a net cash outflow of 4.00 Cr in the latest year. Overall, Chemcrux Enterp. has faced challenges in maintaining profitability and managing its financial health over the observed period.

Who are the top shareholders of the Chemcrux Enterp.?

The top shareholder of Chemcrux Enterprises is Sanjay Marathe, holding 36.46%. The highest public shareholder is Namita Bhandare at 1.49%, while individual investors collectively own 25.88% of the shares.

The top shareholders of Chemcrux Enterprises include the promoters, with Sanjay Marathe holding the highest stake at 36.46%. There are no pledged promoter holdings, and the company does not have any mutual funds or foreign institutional investors (FIIs) holding shares. The highest public shareholder is Namita Bhandare, who owns 1.49% of the company. Additionally, individual investors collectively hold 25.88% of the shares.

What is the technical trend for Chemcrux Enterp.?

As of June 4, 2025, Chemcrux Enterprises has shifted to a bearish trend with moderate strength, indicated by bearish daily moving averages, a declining weekly RSI, a bearish monthly MACD, and a 40.43% decline over the past year.

As of 4 June 2025, the technical trend for Chemcrux Enterp. has changed from mildly bearish to bearish. The current stance is bearish with moderate strength. Key indicators driving this include the daily moving averages indicating bearish momentum, the weekly RSI showing bearish conditions, and the monthly MACD reflecting a bearish trend. Additionally, the Bollinger Bands on both weekly and monthly time frames are mildly bearish, reinforcing the overall bearish outlook. The stock's performance over the past year shows a significant decline of 40.43%, further supporting the bearish sentiment.

What is the bonus history of the Chemcrux Enterp.?

Chemcrux Enterprises Ltd issued a 2:1 bonus on September 6, 2021, with a record date of September 7, 2021, granting shareholders two additional shares for every one share held.

Chemcrux Enterprises Ltd has a bonus history that includes a 2:1 bonus issue announced with an ex-date of September 6, 2021. The record date for this bonus was September 7, 2021. This means that shareholders received two additional shares for every one share they held as of the record date. If you have any more questions about the company or its financial activities, feel free to ask!

Has Chemcrux Enterp. declared dividend?

Chemcrux Enterprises Ltd has declared a 10% dividend, amounting to 1 per share, with an ex-date of September 6, 2024. While the company shows significant negative total returns in the short to medium term, it has delivered positive returns over the longer term.

Chemcrux Enterprises Ltd has declared a 10% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 10%<BR>- Amount per share: 1 per share<BR>- Ex-date: 06 Sep 2024<BR><BR>Dividend Yield: 0.73%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -26.3%, the dividend return was 0%, resulting in a total return of -26.3%.<BR><BR>Over the past year, the price return was -40.01%, the dividend return was 0.43%, leading to a total return of -39.58%.<BR><BR>In the 2-year period, the price return was -58.28%, the dividend return was 0.93%, which resulted in a total return of -57.35%.<BR><BR>For the 3-year period, the price return was -32.56%, the dividend return was 2.07%, culminating in a total return of -30.49%.<BR><BR>In the last 4 years, the price return was 37.18%, the dividend return was 7.64%, resulting in a total return of 44.82%.<BR><BR>Over the past 5 years, the price return was 350.98%, the dividend return was 17.00%, leading to a total return of 367.98%.<BR><BR>Overall, while Chemcrux Enterprises Ltd has declared a dividend, the total returns over various periods show significant fluctuations, with negative returns in the short to medium term but positive returns over the longer term.